Trilogy Capital’s Illumina ILMN Stock Holding History

Trilogy Capital’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-148	Closed	-$53K	–	337
2018 Q3	$53K	Buy	148 +31	+26%	+$9.93K	0.01%	191
2018 Q2	$32K	Hold	117	–	–	﹤0.01%	214
2018 Q1	$27K	Buy	+117	New	+$26.8K	﹤0.01%	204

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trilogy Capital's ILMN Position: Q4 2018 in Review

Trilogy Capital sold out of Illumina (ILMN) in Q4 2018, closing a stake of 148 shares — an estimated $53K sold.

Trilogy Capital first reported a position in ILMN in Q1 2018 and held it in 3 quarters. The position peaked at $53K in Q3 2018. 843 funds tracked by Wall St. Rank hold ILMN as of Q4 2018.

Trilogy Capital reported no remaining Illumina position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 148 Illumina shares in Q4 2018, an estimated $53K.
Trilogy Capital first reported a position in Illumina in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Illumina position peaked at $53K in Q3 2018.
843 funds tracked by Wall St. Rank held Illumina as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.